Gipuzkoa
Campus
![Foto de Gipuzkoa](/img/uploaded/FCB09D7335FCA2A3AE8EE86EE65B5B3A.jpg)
![Foto de GlaxoSmithKline (United Kingdom)](/img/noimage_org.png)
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoPublicaciones en colaboración con investigadoras/es de GlaxoSmithKline (United Kingdom) (6)
2024
-
High-throughput virtual search of small molecules for controlling the mechanical stability of human CD4
Journal of Biological Chemistry, Vol. 300, Núm. 4
2022
-
Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort
npj Parkinson's Disease, Vol. 8, Núm. 1
2021
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
2019
-
Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)
Parkinsonism and Related Disorders, Vol. 62, pp. 201-209
1997
-
Eficacia y seguridad de la nabumetona en el tratamiento de la gonartrosis: Ensayo clinico comparativo con aceclofenaco
Medicina Clinica, Vol. 109, Núm. 4, pp. 130-134